Eva Prieschl-Grassauer
Founder chez MARINOMED BIOTECH AG
Profil
Eva Prieschl-Grassauer is the founder and Chief Scientific Officer at Marinomed Biotech AG, which is founded in 2006.
She previously worked as Head-Laboratory at AUSTRIANOVA Biomanufacturing AG from 2002 to 2006, and as Head-Allergy Program at Novartis Austria GmbH.
She also worked as a Product Manager at Wyeth Pharmaceuticals BV in 2002 and as a Project Manager at Onepharma in 2006.
Dr. Prieschl-Grassauer holds a doctorate degree from the University of Vienna.
Postes actifs de Eva Prieschl-Grassauer
| Sociétés | Poste | Début |
|---|---|---|
| MARINOMED BIOTECH AG | Founder | 01/01/2006 |
Anciens postes connus de Eva Prieschl-Grassauer
| Sociétés | Poste | Fin |
|---|---|---|
| Onepharma | Corporate Officer/Principal | 01/07/2006 |
AUSTRIANOVA Biomanufacturing AG
 AUSTRIANOVA Biomanufacturing AG BiotechnologyHealth Technology AUSTRIANOVA Biomanufacturing AG engages in the developmente of proprietary drug delivery technologies in orphan niche indications in oncology. It offers NovaCaps, which targets tumours in pancreatic cancer. The company was founded in 2001 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | 01/01/2006 |
| Wyeth Pharmaceuticals BV | Corporate Officer/Principal | 01/10/2002 |
Novartis Austria GmbH
 Novartis Austria GmbH Pharmaceuticals: MajorHealth Technology Novartis Austria GmbH operates as a holding company, which engages in the development and production of pharmaceutical products. The company was founded on January 30, 2006 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | - |
Formation de Eva Prieschl-Grassauer
| University of Vienna | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MARINOMED BIOTECH AG | Health Technology |
| Entreprise privées | 4 |
|---|---|
AUSTRIANOVA Biomanufacturing AG
AUSTRIANOVA Biomanufacturing AG BiotechnologyHealth Technology AUSTRIANOVA Biomanufacturing AG engages in the developmente of proprietary drug delivery technologies in orphan niche indications in oncology. It offers NovaCaps, which targets tumours in pancreatic cancer. The company was founded in 2001 and is headquartered in Vienna, Austria. | Health Technology |
Novartis Austria GmbH
Novartis Austria GmbH Pharmaceuticals: MajorHealth Technology Novartis Austria GmbH operates as a holding company, which engages in the development and production of pharmaceutical products. The company was founded on January 30, 2006 and is headquartered in Vienna, Austria. | Health Technology |
| Wyeth Pharmaceuticals BV | |
| Onepharma |
